NAME OF THE INTERMEDIATES CAS NO END PRODUCT
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone 22246-18-0 Aripiperazole
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone 129722-34-5 Aripiperazole
(2-Acetyl-4-methylphenyl)Trimethylammoniumiodide 1069-62-1 Deutetrabenazine,Tetrabenazine,Valbenazine
3,4-dimethoxyphenethyleneamineHydrochloride 120-20-7 Tetrabenazine, Valbenazine
6,7-Dimethoxy-3,4 -dihydroisoquinoline hydrochloride 20232-39-7 Tetrabenazine, Valbenazine
9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one 89929-27-1 Deutetrabenazine
6,7-Dihydroxy-3,4-dihydroisoquinoline
3,4-dihydroisoquinoline-6,7-diol
4602-83-9 Deutetrabenazine,
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 145783-15-9 Ticagrelor
(1R,2S)-2-(3,4-Difluorophenyl) cyclopropylamine.
(R)-2-hydroxy-2-phenyl acetate
376608-71-8 Ticagrelor
(R)-5-(2-Aminopropyl)-1-(3 -benzyloxypropyl)indoline-7-carbonitriletartaric acid 239463-85-5 Silodosin
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethylmethanesulfonate 160969-03-9 Silodosin
(S)-((2-Guanidino-4-thiazolyl) methylisothioureadihydrochloride 88046-01-9 Famotidine
Indole-3-Carbinol 700-06-1 Nutraceuticals
3,3′-Diindolylmethane(DIM) 1968-05-4 Nutraceuticals

Remarks:

* Under development/evaluation. ✔ Available.

Patent:All transactions are carried out in conformity with patent laws applicable in the user country, responsibility with respect to third parties rights in a specific country lies exclusively with the user.

The above products are offered as per BP/EP/USP/JP and FP and as per customer’s in-house specification.Also available in Microfine.